Thus, the Work from Anywhere (WFA) revolution was born — a paradigm shift allowing employees to perform their duties from ...

The incidence of OAC in short-segment BO is under 1 per 500 patients per year. Previous presentation: These data were presented in poster form at the annual meeting of the American Gastroenterological ...

On May 16, 2025, FibroBiologics, Inc. (NASDAQ:FBLG) announced a poster presentation at the Society ... In experiment two, there was a comparative analysis of the therapeutic efficacy between ...

today announced the poster presentation of two abstracts at the 2025 American Society for Clinical Oncology (ASCO) Annual Meeting, taking place May 30-June 3 in Chicago. Title: Phase 1/2 Duravelo ...

"We are honored that our Trial in Progress poster has been accepted for presentation at ASCO 2025 ... thinking of our people and exacting analysis of our research processes.

BeiGene , Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Lt ...

Poster presentation to highlight the ongoing global Phase 3 ASP-1929-381 study at ASCO 2025 Global patient enrollment continues, with Taiwan now actively enrolling following the U.S., and Japan ...

Faculty from Roswell Park Comprehensive Cancer Center are among the international experts invited to share their research findings at the American Society of Clinical Oncology (ASCO) annual meeting ...

Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, announced the U.S. launch of the SOUNDSTAR CRYSTALtm Ultrasound Catheter for intracardiac echocardiography (ICE) imaging in ...

With two abstracts selected for rapid oral presentation, these data reflect ... Results from the final analysis of the RATIONALE-213 study demonstrate that, using a PET-guided approach, TEVIMBRA ...